
The Finnish Competition and Consumer Authority (FCCA) has recommended to the Finnish Market Court that it block Mehiläinen’s takeover of rival Pihlajalinna, reported Laing.
Last year private healthcare provider Mehiläinen, of which is 57% is owned by CVC Capital Partners, made a €361.9 million (US$424.5 million) recommended cash offer for rival Pihlajalinna.
It offered €16 (US$18.78)per share, which is a weighty 46% premium to the closing price of Pihlajalinna shares on November 4 last year.
“We regret that the FCCA has decided to propose to the market court to prohibit the transaction. We believe the remedies offered by Mehiläinen in the course of the review process were extensive in scope and addressed all competition concerns raised by the FCCA. We will now review the FCCA’s proposal in detail and thereafter decide, in consultation with Pihlajalinna, on the best way forward,” said Mehiläinen chief executive Janne-Olli Järvenpää.
Pihlajalinna’s board had unanimously recommended the deal and getting on for two-thirds of shareholders had said that they would accept the offer.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas